Bioluminomics™ implies non-subjective, instrument-based, standardized and validated assays. Bioluminomics™ provides ease of use and cost- efficient assays. Bioluminomics means accuracy, reliability and reproducibility.
Since 2002, HemoGenix® has developed three primary bioluminomics assay platforms for a variety of different applications, including toxicity testing, basic and veterinary research and stem cell quality control and potency testing for stem cell transplantation and umbilical cord blood banks.
Bioluminomics™ provides flexibility and diversity allowing virtually any mammalian cell type to be analyzed for viability, proliferation status or potential or inhibition / cytotoxicity. In fact, between the three HemoGenix® bioluminomics™ assay platforms available for contract research services or as assay kits for in-house implementation, more than 50 different cell types from 14 cell systems derived from 7 different species can be measured, compared and ranked for cellular functionality.